BMI, kg/m2 | Cases, no. | Strenuous RPA, h/wk/y | P trend | P homogeneity of trends | ||
---|---|---|---|---|---|---|
≤0.50 | 0.51–3.50 | ≥3.51 | ||||
 | Adjusted HR (95 % CI) | Adjusted HR (95 % CI) | Adjusted HR (95 % CI) |  |  | |
Among all women | ||||||
 TNBC (ER-/PR-/HER2-) | ||||||
  Long-terma | ||||||
   BMI <25 | 195 | Referent | 0.88 (0.64–1.22) | 0.62 (0.39–0.99) | 0.05 | 0.54 |
   BMI ≥25 | 139 | Referent | 0.85 (0.59–1.24) | 0.78 (0.45–1.36) | 0.37 |  |
  Baselineb | ||||||
   BMI <25 | 195 | Referent | 1.04 (0.76–1.42) | 0.60 (0.37–0.97) | 0.05 | 0.40 |
   BMI ≥25 | 139 | Referent | 0.72 (0.47–1.10) | 0.48 (0.21–1.10) | 0.04 |  |
 Luminal A-like (ER+ or PR+ plus HER2-) | ||||||
  Long-terma | ||||||
   BMI <25 | 1484 | Referent | 0.95 (0.84–1.07) | 0.93 (0.79–1.09) | 0.39 | 0.71 |
   BMI ≥25 | 1119 | Referent | 0.87 (0.76–0.99) | 0.90 (0.74–1.08) | 0.25 |  |
  Baselineb | ||||||
   BMI <25 | 1484 | Referent | 0.89 (0.79–1.00) | 0.88 (0.76–1.03) | 0.08 | 0.31 |
   BMI ≥25 | 1119 | Referent | 0.87 (0.75–1.00) | 1.06 (0.86–1.32) | 0.99 |  |
Among peri- and postmenopausal women at baseline | ||||||
 TNBC (ER-/PR-/HER2-) | ||||||
  Long-terma | ||||||
   BMI <25 | 118 | Referent | 1.01 (0.67–1.53) | 0.78 (0.41–1.47) | 0.45 | 0.99 |
   BMI ≥25 | 89 | Referent | 0.89 (0.56–1.43) | 0.83 (0.40–1.73) | 0.60 |  |
  Baselineb | ||||||
   BMI <25 | 118 | Referent | 1.26 (0.83–1.90) | 0.69 (0.35–1.36) | 0.42 | 0.06 |
   BMI ≥25 | 89 | Referent | 0.56 (0.31–1.02) | 0.28 (0.07–1.17) | 0.02 |  |
 Luminal A-like (ER+ or PR+ plus HER2-) | ||||||
  Long-terma | ||||||
   BMI <25 | 940 | Referent | 0.97 (0.84–1.12) | 0.90(0.73–1.12) | 0.34 | 0.39 |
   BMI ≥25 | 794 | Referent | 0.86 (0.73–1.00) | 0.80(0.63–1.02) | 0.06 |  |
  Baselineb | ||||||
   BMI <25 | 940 | Referent | 0.93 (0.80–1.09) | 0.86 (0.70–1.05) | 0.13 | 0.47 |
   BMI ≥25 | 794 | Referent | 0.90 (0.75–1.07) | 1.01 (0.77–1.32) | 0.78 |  |